Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $2250.0000 (-10%) ($2250.0000 - $2250.0000) on Wed. Nov. 22, 2006. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.86% (three month average) | RSI | 39 | Latest Price | $2250.0000(-10%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -3.9% a day on average for past five trading days. | Weekly Trend | CAPR declines -11.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) LQD(3%) TLT(3%) XLP(3%) EWI(2%) EWP(2%) | Factors Impacting CAPR price | CAPR will decline at least -3.93% in a week (0% probabilities). GLD(-0%) FXI(0%) XLU(1%) XLK(1%) VWO(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.93% (StdDev 7.86%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $2850.5 | 5 Day Moving Average | $2480(-9.27%) | 10 Day Moving Average | $2744.29(-18.01%) | 20 Day Moving Average | $2850.5(-21.07%) | To recent high | -40% | To recent low | 0% | Market Cap | $44.32b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |